In the published article, there was an error regarding the affiliations for Magdalena Więdłocha, Piotr Marcinowicz, and Agata Szulc. As well as having affiliation 1, Magdalena Więdłocha and Piotr Marcinowicz should also have an additional affiliation 2: KeyClinic, Warsaw, Poland. As well as having affiliation 1, Agata Szulc should also have an additional affiliation 3: MindHealth, Warsaw, Poland.
In the published article, there was an error in the Conflict of interest statement. The original Conflict of interest statement was: “The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.” It did not include all of the authors' affiliations and potential financial conflicts of interest.
Two co-authors of the article (MW and PM) were employed by KeyClinic—a commercial mental health center which provides ketamine and TMS treatment, as one of many services. The center offers multiple psychiatric and psychotherapeutic services and does not focus on ketamine/TMS treatment or market it in any way. Moreover, one of the authors (AS) was employed by Mind Health (a commercial medical center), was a member of Janssen Cilag Advisory Board and gave lectures for Janssen Cilag.
The correct Conflict of interest statement appears below.
Statements
Conflict of interest
MW and PM were employed by KeyClinic. AS was employed by MindHealth, was a member of Janssen Cilag Advisory Board and gave lectures for Janssen Cilag. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
depressive disorders, treatment-resistant depression, transcranial magnetic stimulation, TMS, rTMS, ketamine, combined TMS and ketamine, neuroplasticity
Citation
Dębowska W, Więdłocha M, Dębowska M, Kownacka Z, Marcinowicz P and Szulc A (2024) Corrigendum: Transcranial magnetic stimulation and ketamine: implications for combined treatment in depression. Front. Neurosci. 18:1507512. doi: 10.3389/fnins.2024.1507512
Received
07 October 2024
Accepted
09 October 2024
Published
23 October 2024
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
18 - 2024
Updates
Copyright
© 2024 Dębowska, Więdłocha, Dębowska, Kownacka, Marcinowicz and Szulc.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Weronika Dębowska w.debowska@gmail.com
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.